Equities

PRISM BioLab Co Ltd

206A:TYO

PRISM BioLab Co Ltd

Actions
  • Price (JPY)325.00
  • Today's Change-4.00 / -1.22%
  • Shares traded217.00k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments4,3921,1341,688
Total Receivables, Net554022
Total Inventory------
Prepaid expenses291821
Other current assets, total6.965.481.70
Total current assets4,4831,1981,732
Property, plant & equipment, net000
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets45148.04
Total assets4,5291,2111,740
LIABILITIES
Accounts payable------
Accrued expenses8.285.0628
Notes payable/short-term debt--00
Current portion long-term debt/capital leases--00
Other current liabilities, total1,0125837
Total current liabilities1,0206365
Total long term debt--00
Total debt--00
Deferred income tax------
Minority interest------
Other liabilities, total5.800.170.17
Total liabilities1,0266365
SHAREHOLDERS EQUITY
Common stock1,7141212
Additional paid-in capital3,3311,6291,629
Retained earnings (accumulated deficit)(1542)(493)34
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--00.00
Total equity3,5031,1481,675
Total liabilities & shareholders' equity4,5291,2111,740
Total common shares outstanding363535
Treasury shares - common primary issue--00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.